Regulatory Database
A comprehensive database of drug regulations, guidelines, and standards in China.
-
ChinaIn forceType: RegulationRelease Date: 2022-03-29Implementation Date: 2022-03-29
-
ChinaIn forceType: RegulationRelease Date: 2022-03-29Implementation Date: 2022-03-29
-
ChinaNotice of NMPA on Matters Related to Further Strengthening the Administration of Radioactive Drugs (2022 No. 5)国家药监局关于进一步加强放射性药品管理有关事宜的通告（2022年 第5号）In forceType: NoticeRelease Date: 2022-01-14Implementation Date: 2022-01-14
-
ChinaNotice of NMPA on the Use of the Shortage of Drug Production and Supply and Shutdown Report Information Collection Module国家药监局综合司关于启用短缺药品生产供应及停产报告信息采集模块的通知In forceType: NoticeRelease Date: 2021-11-03Implementation Date: 2021-11-03
-
ChinaNotice of NMPA on the Use of the Production and Supply Information Collection Module for Apis国家药监局综合司关于启用原料药生产供应信息采集模块的通知In forceType: NoticeRelease Date: 2021-11-03Implementation Date: 2021-11-03
-
ChinaAnnouncement on Implementing the Application with Electronic Common Technical Documents国家药监局关于实施药品电子通用技术文档申报的公告（2021年第119号）In forceType: NoticeRelease Date: 2021-09-30Implementation Date: 2021-12-29
-
ChinaNotice on the Addition of Six Substances, namely, 3-Oxo-2-Phenylbutyrate, 3-Oxo-2-Phenylbutyramide, 2-Methyl-3-[3,4-(Methylenedioxy)phenyl]Glycidyl Acetate, 2-Methyl-3-[3,4-(Methylenedioxy)phenyl]Glycidyl Acetate Methyl Ester, Phenylacetonitrile and γ-Butyl Ester, to the Administration of Chemicals Prone to Producing Addictive Substances关于将3-氧-2-苯基丁酸甲酯、3-氧-2-苯基丁酰胺、2-甲基-3-[3,4-(亚甲二氧基)苯基]缩水甘油酸、2-甲基-3-[3,4-(亚甲二氧基)苯基]缩水甘油酸甲酯、苯乙腈和γ-丁内酯6种物质列入易制毒化学品管理的公告In forceType: NoticeRelease Date: 2021-08-25Implementation Date: 2021-09-20
-
ChinaIn forceType: LawRelease Date: 2021-08-20Implementation Date: 2022-03-01
-
ChinaNotice of NMPA on Matters related to the Registration of Drug and Device Combination Products (2021 No. 52)国家药监局关于药械组合产品注册有关事宜的通告（2021年第52号）In forceType: NoticeRelease Date: 2021-07-27Implementation Date: 2021-07-27
-
ChinaIn forceType: RegulationRelease Date: 2021-07-05Implementation Date: 2021-07-05
Most Popular
- Chinese Pharmacopoeia 2020 Edition
- Chinese Pharmacopoeia 9012 Guidelines for Validation of Quantitative Analytical Method of Biological Samples
- Drug Administration Law of the People's Republic of China (2nd Revision)
- Chinese Pharmacopoeia 9001 Guidelines for the Stability Testing of Drug Substances and Preparations
- Provisions for Post-approval Changes of Drugs (Interim)